These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9191478)

  • 21. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic features at ischemia- or infarct-related sites in patients with acute coronary syndrome: morphology changing in a relatively short time.
    Koiwaya Y; Nagoshi T; Doi H; Eto T
    J Cardiol; 2001 Oct; 38(4):187-96. PubMed ID: 11688425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
    Gulba DC
    Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antithrombotics in pre-hospital phase of acute coronary syndromes].
    Collet JP; Dumaine R; Ecollan P; Beygui F; Choussat R; Boon G; Payot L; Montalescot G
    Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1118-22. PubMed ID: 16379108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early prehospital thrombolysis in acute myocardial infarct: a moral obligation?].
    Coccolini S; Fresco C; Fioretti PM
    Ital Heart J Suppl; 2003 Feb; 4(2):102-11. PubMed ID: 12762259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet and anticoagulant use after myocardial infarction.
    Almony GT; Lefkovits J; Topol EJ
    Clin Cardiol; 1996 May; 19(5):357-65. PubMed ID: 8723593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy in the prevention of cardiovascular diseases.
    Mannucci PM; Cimminiello C; Cattaneo M
    Ann Ital Med Int; 1993; 8(3):189-94. PubMed ID: 8217485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of antiplatelet agents in the treatment of ischemic cardiopathy].
    Bonhorst D
    Rev Port Cardiol; 1989 Apr; 8(4):261-4. PubMed ID: 2534356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis in ischemic heart disease.
    Ambrose JA; Weinrauch M
    Arch Intern Med; 1996 Jul; 156(13):1382-94. PubMed ID: 8678707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Main antithrombotic drugs in the therapy and prevention of arterial and venous thrombosis].
    Ferlito S
    Minerva Cardioangiol; 1996 Jun; 44(6):299-312. PubMed ID: 8927260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD; Deykin D
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolytic, antiplatelet and anticoagulant therapy for thrombotic disorders].
    Homma S; Yamaguchi I
    Nihon Rinsho; 1999 Jul; 57(7):1561-8. PubMed ID: 10429458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coronary reocclusion--an unsolved problem in thrombolytic therapy of acute myocardial infarct].
    Huber K
    Z Gesamte Inn Med; 1993; 48(6-7):316-23. PubMed ID: 8333228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of reocclusion after coronary thrombolysis.
    Eisenberg PR
    Z Kardiol; 1993; 82 Suppl 2():175-8. PubMed ID: 8328198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complications after treatment of acute coronary syndrome].
    Kodama K; Hirayama A
    Nihon Rinsho; 1998 Oct; 56(10):2659-65. PubMed ID: 9796335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet and anticoagulation therapy for acute coronary syndromes.
    Bhatt DL; Hulot JS; Moliterno DJ; Harrington RA
    Circ Res; 2014 Jun; 114(12):1929-43. PubMed ID: 24902976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of thrombosis in coronary heart disease.
    de Bono D
    Br Med Bull; 1994 Oct; 50(4):904-10. PubMed ID: 7804737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombocardiology: an update.
    Arnesen H
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):331-3. PubMed ID: 20222811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.